Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements

Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in...

Full description

Saved in:
Bibliographic Details
Published inPharmacogenetics (London) Vol. 4; no. 3; p. 117
Main Authors Tang, B K, Zhou, Y, Kadar, D, Kalow, W
Format Journal Article
LanguageEnglish
Published England 01.06.1994
Subjects
Online AccessGet more information
ISSN0960-314X
DOI10.1097/00008571-199406000-00002

Cover

Loading…
Abstract Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in urine and plasma of 39 healthy subjects. The measurements allowed determinations of: (1) systemic caffeine clearance (CL(caff)); (2) the caffeine metabolite ratio (AFMU + 1X + 1U)/17U determined in an overnight-urine specimen and referred to as CMR, and (3) the ratio (17X + 17U)/137X measured in urine collected between 4 and 5 h after caffeine intake and referred to as PCUR for 'paraxanthine-caffeine urinary ratio'. The PCUR showed a bimodal distribution and a relatively wide variation, CL(caff) and CMR were both normally distributed. The correlation between CL(caff) and CMR was r = 0.77 (p < 0.001), between CLcaff and PCUR r = 0.46 (p < 0.01), and between CMR and PCUR r = 0.40 (p < 0.02). The difference between the correlation coefficients 0.77 and 0.46 was statistically significant (z-test; p < 0.05). The well established decrease of caffeine metabolism by oral contraceptive use was observed with both CL(caff) and CMR but not with PCUR. Examination of possible explanations for the differences between PCUR and CMR led to the finding of a correlation between PCUR and the renal clearance of caffeine (CLr) with r = -0.47 (p < 0.01). Further scrutiny demonstrated that a bimodal or non-normal frequency distribution as shown by PCUR was also shown by CLr and by urine flow rate.
AbstractList Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in urine and plasma of 39 healthy subjects. The measurements allowed determinations of: (1) systemic caffeine clearance (CL(caff)); (2) the caffeine metabolite ratio (AFMU + 1X + 1U)/17U determined in an overnight-urine specimen and referred to as CMR, and (3) the ratio (17X + 17U)/137X measured in urine collected between 4 and 5 h after caffeine intake and referred to as PCUR for 'paraxanthine-caffeine urinary ratio'. The PCUR showed a bimodal distribution and a relatively wide variation, CL(caff) and CMR were both normally distributed. The correlation between CL(caff) and CMR was r = 0.77 (p < 0.001), between CLcaff and PCUR r = 0.46 (p < 0.01), and between CMR and PCUR r = 0.40 (p < 0.02). The difference between the correlation coefficients 0.77 and 0.46 was statistically significant (z-test; p < 0.05). The well established decrease of caffeine metabolism by oral contraceptive use was observed with both CL(caff) and CMR but not with PCUR. Examination of possible explanations for the differences between PCUR and CMR led to the finding of a correlation between PCUR and the renal clearance of caffeine (CLr) with r = -0.47 (p < 0.01). Further scrutiny demonstrated that a bimodal or non-normal frequency distribution as shown by PCUR was also shown by CLr and by urine flow rate.
Author Tang, B K
Zhou, Y
Kadar, D
Kalow, W
Author_xml – sequence: 1
  givenname: B K
  surname: Tang
  fullname: Tang, B K
  organization: Department of Pharmacology, University of Toronto, Ontario, Canada
– sequence: 2
  givenname: Y
  surname: Zhou
  fullname: Zhou, Y
– sequence: 3
  givenname: D
  surname: Kadar
  fullname: Kadar, D
– sequence: 4
  givenname: W
  surname: Kalow
  fullname: Kalow, W
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7920691$$D View this record in MEDLINE/PubMed
BookMark eNotT19LwzAczMNkbtOPIPy-QDVpmqTxbRT_wUAfFPRpJO0vGFmTkqaDfXsr7l6OO47jbk0WIQYkBBi9ZVSrOzqjFooVTOuKylkVf1a5ICuqJS04qz4vyXocfyhlgvNySZZKl1RqtiLHxjiHPiCYEQwMKVoEFxM0X29sW4Jpsz_6fLqHIWYM2ZsD-OAOE4YWITpIGGbLzbmYRogBpuSDSScYvjHEfBp8CzkZn6FHM04J-7llvCIXzhxGvD7zhnw8Prw3z8Xu9eml2e6KljOaC2WZMEZ3ne5kJbi0Do3jrmZVpZUVtFWKSuOk5ErIzlJez_9N3QqLvKtbWm7IzX_vMNkeu_2QfD-P25__l7-9CV_J
CitedBy_id crossref_primary_10_1002_jppr2000303102
crossref_primary_10_1007_s00360_005_0483_3
crossref_primary_10_1046_j_0306_5251_2001_01494_x
crossref_primary_10_1016_S0378_4274_98_00346_4
crossref_primary_10_1177_009127009703700121
crossref_primary_10_1016_S0009_9236_97_90045_X
crossref_primary_10_1111_j_2042_7158_2011_01326_x
crossref_primary_10_2165_00003088_200342150_00006
crossref_primary_10_1016_S0031_3955_05_70338_2
crossref_primary_10_1002_j_2055_2335_2008_tb00845_x
crossref_primary_10_1080_17512433_2021_1997585
crossref_primary_10_1016_S0048_9697_01_00732_X
crossref_primary_10_1111_j_1365_2125_1995_tb04411_x
crossref_primary_10_1046_j_1365_2125_1998_00776_x
crossref_primary_10_1111_obr_12869
crossref_primary_10_1186_bcr797
crossref_primary_10_1007_s10517_011_1243_x
crossref_primary_10_1186_bcr798
crossref_primary_10_1016_j_freeradbiomed_2003_11_013
crossref_primary_10_1093_carcin_bgn136
crossref_primary_10_3109_00365519609088615
crossref_primary_10_1089_dna_1996_15_273
crossref_primary_10_1371_journal_pone_0183424
crossref_primary_10_1016_S0090_9556_24_14946_X
crossref_primary_10_1097_00007691_199610000_00011
crossref_primary_10_1097_00008571_200004000_00001
crossref_primary_10_1097_00007691_200212000_00006
crossref_primary_10_1007_s00228_010_0964_5
crossref_primary_10_1515_DMDI_2004_20_4_247
crossref_primary_10_1016_S0378_4347_98_00016_4
crossref_primary_10_1111_j_1600_0773_1995_tb00134_x
crossref_primary_10_1371_journal_pone_0117328
crossref_primary_10_1016_j_fct_2004_01_010
crossref_primary_10_1016_S0378_4274_98_00252_5
crossref_primary_10_1097_00008571_200011000_00004
crossref_primary_10_1515_dmpt_2015_0001
crossref_primary_10_1016_S0031_3955_05_70463_6
crossref_primary_10_1016_S0009_9236_98_90105_9
crossref_primary_10_1046_j_1365_2125_2000_00128_x
crossref_primary_10_1016_0306_3623_95_02014_4
crossref_primary_10_1016_j_talanta_2021_122658
crossref_primary_10_1016_S0006_2952_97_00263_3
crossref_primary_10_1078_1438_4639_00088
crossref_primary_10_1128_AAC_46_8_2358_2364_2002
crossref_primary_10_1097_00007691_200008000_00008
crossref_primary_10_1177_074823379701300205
crossref_primary_10_1016_S0278_6915_01_00005_9
crossref_primary_10_1016_S1570_0232_03_00065_5
crossref_primary_10_3109_00365519609090590
crossref_primary_10_1017_S109285290001186X
crossref_primary_10_1007_s00228_005_0082_y
crossref_primary_10_1097_00004714_199806000_00004
crossref_primary_10_1002_j_1552_4604_1997_tb04321_x
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/00008571-199406000-00002
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 7920691
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID .Z2
123
4Q1
4Q2
4Q3
53G
5RE
5VS
8L-
AAAAV
AAIQE
AAMTA
AARTV
AAYEP
ABBUW
ABDIG
ABJNI
ABXVJ
ACDDN
ACEWG
ACGFS
ACILI
ACWDW
ACWRI
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AEETU
AFDTB
AFUWQ
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
AWKKM
BQLVK
BS7
C45
CAG
CGR
COF
CS3
CUY
CVF
DIWNM
DUNZO
E.X
EBS
ECM
EIF
EJD
EX3
F2K
F2L
F5P
FL-
IH2
IKREB
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
NPM
N~M
OAG
OAH
OCUKA
ODA
OJAPA
OL1
OLG
OLV
OLW
OLZ
OPC
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
R58
S4R
S4S
T8P
TEORI
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
ZFV
ZGI
ZZMQN
ID FETCH-LOGICAL-c310t-7b15aa9dd9d64536bfeaf3f814497b50c7706af663756db038060a8c5be3d8c02
ISSN 0960-314X
IngestDate Wed Feb 19 01:21:16 EST 2025
IsPeerReviewed false
IsScholarly false
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c310t-7b15aa9dd9d64536bfeaf3f814497b50c7706af663756db038060a8c5be3d8c02
PMID 7920691
ParticipantIDs pubmed_primary_7920691
PublicationCentury 1900
PublicationDate 1994-06-01
PublicationDateYYYYMMDD 1994-06-01
PublicationDate_xml – month: 06
  year: 1994
  text: 1994-06-01
  day: 01
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmacogenetics (London)
PublicationTitleAlternate Pharmacogenetics
PublicationYear 1994
SSID ssj0015332
Score 1.333652
Snippet Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine...
SourceID pubmed
SourceType Index Database
StartPage 117
SubjectTerms Adult
Biotransformation
Caffeine - administration & dosage
Caffeine - pharmacokinetics
Caffeine - urine
Cytochrome P-450 CYP1A2
Cytochrome P-450 Enzyme System - genetics
Cytochrome P-450 Enzyme System - metabolism
Female
Humans
Kidney - metabolism
Male
Metabolic Clearance Rate
Molecular Probes
Oxidoreductases - genetics
Oxidoreductases - metabolism
Phenotype
Reference Values
Title Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements
URI https://www.ncbi.nlm.nih.gov/pubmed/7920691
Volume 4
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEG42SiAX0WjwTR0kl2Rknt093uKqBEHZwwajl9BPIpidxZ0I63_wP1v9mO0hRlEvs0sPDDNdH0VV9VdfEfJMVa1mreWZMUWT1ZbTTJamzQoh8oopVVHqGoXfvafHJ_Xb0-Z0MvkxYi1d9vK5-n5tX8n_WBXX0K6uS_YfLLt5KC7gf7QvXtHCeP0rG0-FtcaFiWJ1IBzVSgYJ7-nHWXFUep0MNxrCZf3Lrne8IC-xEceSuDjxq3HR6DB0B5Hgiu-OSOeoX12_Xn5WfopEf3CRiomrcUQ7i9rX-JLGSz6PZoRsigzzWJV-maqqn867y-T_ncsXOpC9X6WVL-Hk6UOqTQSR4YFDNRQZqfPygYM5-Nt6BKtq5DuL0MT5i08PWsGBUscKx4zBICQ2xPtu7X5k6uWFtzVry5yGMWB_vHlFazve2SJbmHS4Kaqu9BOPpDAu9kdSwydFWtigAHrdu-2Q7fjEK0mLD17mt8mtmHXAUYDQHTIxi12yHeaQrnfJfjTi-hDmqR9vdQj7MEvS5uu75NuAOBArEOARB4g4CIiDAXEvYIM32OANOgsebxDxBt0CIt4g4Q083mCMt3vk5M3r-fQ4i5M7MoXpQp8xWTRCtFq3mtZNRaU1wlaWY_beMtnkirGcCovRLmuolnnFcdcEV400leYqL_fIjUW3MPcJ4O5RoxX-sKJWXHJpmlpzN57atLyUD8he2NmzZZBnOYtb_vB3Nx6RnYTVx-SmRW9gnmBo2cun3uQ_AasadSU
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caffeine+as+a+probe+for+CYP1A2+activity%3A+potential+influence+of+renal+factors+on+urinary+phenotypic+trait+measurements&rft.jtitle=Pharmacogenetics+%28London%29&rft.au=Tang%2C+B+K&rft.au=Zhou%2C+Y&rft.au=Kadar%2C+D&rft.au=Kalow%2C+W&rft.date=1994-06-01&rft.issn=0960-314X&rft.volume=4&rft.issue=3&rft.spage=117&rft_id=info:doi/10.1097%2F00008571-199406000-00002&rft_id=info%3Apmid%2F7920691&rft_id=info%3Apmid%2F7920691&rft.externalDocID=7920691
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-314X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-314X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-314X&client=summon